Glenmark seals brand buyout in South Africa

Glenmark Pharma's South African subsidiary "� Bouwer-Bartlett (Pty) Ltd "� has acquired seven products and 11 presentations from PD Pharmaceuticals (Pty) Ltd for an undisclosed amount. The brands, collectively, are expected to garner sales of $2-3 million in the current financial year.

Bouwer-Bartlett, which has obtained global intellectual property (IP) rights for the products, will initially market the products within South Africa and gradually sell them in other geographies.

The basket, acquired, comprises anti-diarrhoeal, anti-inflammatory, analgesic, expectorant, anti-protozoal, anti-acid and multi-vitamin products.

Glenn Saldanha, CEO and managing director, Glenmark Pharmaceuticals, said the purchase of the seven PD Pharma products followed Glenmark's acquisition of Bouwer-Bartlett, a sales and marketing company in South Africa in December 2005.